Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jeremy Martin Davis is active.

Publication


Featured researches published by Jeremy Martin Davis.


Archive | 2003

Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors

Daniel Christopher Brookings; Jeremy Martin Davis; Barry John Celltech R D Limited Langham


Archive | 2002

Bicyclic oxopyridine and oxopyrimidine derivatives

Jeremy Martin Davis; Daniel Christopher Brookings; Barry John Langham


Bioorganic & Medicinal Chemistry Letters | 2007

4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation

Terry V. Hughes; Stuart L. Emanuel; Amanda K. Beck; Steven K. Wetter; Peter J. Connolly; Prabha Karnachi; Michael Reuman; Jabed Seraj; Angel R. Fuentes-Pesquera; Robert H. Gruninger; Steven A. Middleton; Ronghui Lin; Jeremy Martin Davis; David Festus Charles Moffat


Archive | 2003

bicyclic heteroaromatic compounds as kinase inhibitors.

Daniel Christopher Brookings; Jeremy Martin Davis; Barry John Celltech R D Limited Langham


Archive | 2004

Thienopyridone derivatives as kinase inhibitors

Daniel Christopher Brookings; Jeremy Martin Davis; Barry John Celltech R D Limited Langham


Archive | 2009

THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS

Martin Clive Hutchings; Sarah Catherine Archibald; Daniel Christopher Brookings; Jeremy Martin Davis; James Andrew Johnson; Barry John Langham; Judi Charlotte Neuss


Bioorganic & Medicinal Chemistry Letters | 2007

Synthesis and biological study of 2-amino-4-aryl-5-chloropyrimidine analogues as inhibitors of VEGFR-2 and cyclin dependent kinase 1 (CDK1).

Shenlin Huang; Ronghua Li; Peter J. Connolly; Stuart L. Emanuel; Angel R. Fuentes-Pesquera; Mary Adams; Robert H. Gruninger; Jabed Seraj; Steven A. Middleton; Jeremy Martin Davis; David Festus Charles Moffat


Archive | 2004

Thieno-pyridinone derivatives as kinase inhibitors

Rikki Peter Celltech R D Limited Alexander; Jeremy Martin Davis; Martin Clive Hutchings; Victoria Elizabeth Laing; Graham Trevitt


Bioorganic & Medicinal Chemistry Letters | 2007

Novel nucleotide triphosphates as potent P2Y2 agonists.

Daniel Christopher Brookings; Richard Davenport; Jeremy Martin Davis; Frances Celia Anne Galvin; Steve Lloyd; Stephen R. Mack; Raymond J. Owens; Verity Margaret Sabin; Joanne Wynn


Archive | 2002

Non-natural nucleotides and dinucleotides

Jeremy Martin Davis; Stephen R. Mack; Verity Margaret Sabin; Richard John Davenport

Researchain Logo
Decentralizing Knowledge